TC
CNMD icon

TFS Capital’s CONMED CNMD Stock Holding History

TFS Capital’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-17,294
Closed -$881K – 70
2017
Q2 		$881K Buy
+17,294
New +$856K 0.35% 80
2016
Q2 		– Sell
-13,780
Closed -$578K – 993
2016
Q1 		$578K Sell
13,780
-58,818
-81% -$2.31M 0.08% 408
2015
Q4 		$3.2M Buy
72,598
+48,192
+197% +$2.09M 0.34% 70
2015
Q3 		$1.17M Sell
24,406
-21,831
-47% -$1.2M 0.11% 301
2015
Q2 		$2.69M Buy
46,237
+16,407
+55% +$885K 0.26% 93
2015
Q1 		$1.51M Buy
+29,830
New +$1.46M 0.15% 208
2014
Q4 		– Sell
-42,141
Closed -$1.55M – 1003
2014
Q3 		$1.55M Sell
42,141
-5,105
-11% -$203K 0.13% 228
2014
Q2 		$2.09M Buy
47,246
+37,652
+392% +$1.71M 0.16% 171
2014
Q1 		$417K Buy
9,594
+320
+3% +$14.3K 0.03% 825
2013
Q4 		$394K Buy
9,274
+2,956
+47% +$112K 0.02% 949
2013
Q3 		$215K Sell
6,318
-12,661
-67% -$413K 0.01% 1229
2013
Q2 		$593K Buy
+18,979
New +$616K 0.02% 834

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TFS Capital's CNMD Position: Q3 2017 in Review

TFS Capital sold out of CONMED (CNMD) in Q3 2017, closing a stake of 17,294 shares — an estimated $881K sold.

TFS Capital first reported a position in CNMD in Q2 2013 and held it in 12 quarters. The position peaked at $3.2M in Q4 2015. 144 funds tracked by Wall St. Rank hold CNMD as of Q3 2017.

  • TFS Capital reported no remaining CONMED position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 17,294 CONMED shares in Q3 2017, an estimated $881K.
  • TFS Capital first reported a position in CONMED in Q2 2013 and held it in 12 quarters.
  • TFS Capital's CONMED position peaked at $3.2M in Q4 2015.
  • 144 funds tracked by Wall St. Rank held CONMED as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.